INBRX-121

N/A

Report date: 2023/11/01 09:26:24

Base Information

Drug NameINBRX-121
Drug Alias NameINBRX121
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonistsNatural cytotoxicity triggering receptor 1 inhibitors
TargetsInterleukin-2 receptorNatural cytotoxicity triggering receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInhibrx
China Registration ClassN/A

Develop Information

Active CompaniesInhibrx
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A